Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Natalie A Stemberger"'
Autor:
Deirdre A Collins, Anke Hoskins, Jacinta Bowman, Jade Jones, Natalie A Stemberger, Peter C Richmond, Amanda J Leach, Deborah Lehmann
Publikováno v:
PLoS ONE, Vol 8, Iss 12, p e82280 (2013)
BACKGROUND: Invasive pneumococcal disease (IPD) continues to occur at high rates among Australian Aboriginal people. The seven-valent pneumococcal conjugate vaccine (7vPCV) was given in a 2-4-6-month schedule from 2001, with a 23-valent pneumococcal
Externí odkaz:
https://doaj.org/article/3bb905a781294a2d96d08445c629ed61
Autor:
Anke Hoskins, Amanda J. Leach, Jacinta Bowman, Tom Snelling, Deborah Lehmann, Deirdre A. Collins, Natalie A. Stemberger, Kalpani Senasinghe
Publikováno v:
Pneumonia
Pneumonia, Vol 9, Iss 1, Pp 1-11 (2017)
Pneumonia, Vol 9, Iss 1, Pp 1-11 (2017)
Background The 7-valent pneumococcal conjugate vaccine (PCV7) was introduced to prevent invasive pneumococcal disease (IPD) in Western Australian (WA) Aboriginal people in 2001. PCV13 replaced PCV7 in July 2011, covering six additional pneumococcal s
Autor:
Katherine A. Hammer, Brian W. Skelton, Pan Yu Wong, Scott G. Stewart, Nikki Y. T. Man, Allan J. McKinley, Nigel A. Lengkeek, Niki F. Foster, Ramiz A. Boulos, Thomas V. Riley, Boris Martinac, Natalie A. Stemberger
Publikováno v:
Chemistry - A European Journal. 19:17980-17988
Herein we describe the preparation and structure-activity relationship studies on range of stilbene based compounds and their antibacterial activity. Two related compounds, each bearing carboxylic acid moieties, exhibit good activity against several
Autor:
Peter Richmond, Natalie A. Stemberger, Deirdre A. Collins, Amanda J. Leach, Deborah Lehmann, Anke Hoskins, Jacinta Bowman, Jade Jones
Publikováno v:
PLoS ONE
PLoS ONE, Vol 8, Iss 12, p e82280 (2013)
PLoS ONE, Vol 8, Iss 12, p e82280 (2013)
BACKGROUND: Invasive pneumococcal disease (IPD) continues to occur at high rates among Australian Aboriginal people. The seven-valent pneumococcal conjugate vaccine (7vPCV) was given in a 2-4-6-month schedule from 2001, with a 23-valent pneumococcal
Autor:
Deirdre A. Collins, Anke Hoskins, Thomas Snelling, Kalpani Senasinghe, Jacinta Bowman, Natalie A. Stemberger, Amanda J. Leach, Deborah Lehmann
Publikováno v:
Pneumonia, Vol 9, Iss 1, Pp 1-11 (2017)
Abstract Background The 7-valent pneumococcal conjugate vaccine (PCV7) was introduced to prevent invasive pneumococcal disease (IPD) in Western Australian (WA) Aboriginal people in 2001. PCV13 replaced PCV7 in July 2011, covering six additional pneum
Externí odkaz:
https://doaj.org/article/69213d6870e949e3909c5d8c3f8582b1